Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer

Clinical trial NCT00641303 · COMPLETED

Trial details

NCT number: NCT00641303
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Anxiety Disorder Breast Cancer Depression Fatigue Hot Flashes Pain Sleep Disorders

Start date: 2008-05-01
Primary completion: 2011-10-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.